Are you Dr. Schwarz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-4015
Summary
- Dr. James Schwarz, MD is an oncologist in Omaha, Nebraska. He is an Assistant Professor at University of Nebraska Medical.
Publications & Presentations
PubMed
- 26 citationsPhase Ib/II clinical trial of pembrolizumab with bevacizumab for metastatic renal cell carcinoma: BTCRC-GU14-003Arkadiusz Z. Dudek, Li C Liu, Shilpa Gupta, Theodore F. Logan, Eric A. Singer
Journal of Clinical Oncology. 2020-02-25 - 54 citationsRamucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): ove...Daniel P. Petrylak, Ronald de Wit, Kim N. Chi, Alexandra Drakaki, Cora N. Sternberg
The Lancet. Oncology. 2020-01-01 - 16 citationsPhase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarc...Chi Lin, Vivek Verma, Audrey J. Lazenby, Quan P. Ly, Lyudmyla Berim
American Journal of Clinical Oncology. 2019-10-01